Eichenauer, D. A., Plütschow, A., Kreissl, S., Sökler, M., Hellmuth, J. C., Meissner, J., Mathas, S., Topp, M. S., Behringer, K., Klapper, W., Kuhnert, G., Dietlein, M., Kobe, C., Fuchs, M., Diehl, V., Engert, A., & Borchmann, P. (n.d.). incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group. Lancet oncology, 18(12), 1680–1687. http://access.bl.uk/ark:/81055/vdc_100054258757.0x000018